A Single-Step Synthesis of 4-Oxazolin-2-ones
N-(Benzyl)-4,5-dimethyl-4-oxazolin-2-one (1g) and 1,3-Dibenzyl-4,5- to method C, with 3b (0.10 g, 1.34 mmol), 4i (0.22 g, 1.63 mmol),
dimethyl-1H-imidazol-2(3H)-one (11a): Synthesized according to
method A, with 3a (0.88 g) and 4g (1.33 g), 1g (1.61 g, 79%) and
11a (0.615 g, 21%) as white powders were afforded. Data for 1g: Rf
and Et3N (0.13 g, 1.35 mmol), 9c (0.192 g, 75%) was afforded. Rf
= 0.27 (hexane/EtOAc, 7:3); m.p. 56–57 °C. 1H NMR (300 MHz,
CDCl3): δ = 1.90 (d, J = 1.4 Hz, 3 H, CH3C-4), 2.39 (s, 3 H,
= 0.25 (hexane/EtOAc, 7:3); m.p. 95–96 °C. 1H NMR (300 MHz, CH3Ar), 6.70 (q, J = 1.4 Hz, 1 H, 5-H), 7.08 (dm, J = 7.7 Hz, 1
CDCl3): δ = 1.82 (s, 3 H, CH3C-4), 2.02 (s, 3 H, CH3C-5), 4.73
H, Ar-H), 7.13 (br. s, 1 H, Ar-H), 7.21 (br. d, J = 7.7 Hz, 1 H, Ar-
(s, 2 H, PhCH2N-3), 7.20–7.42 (m, 5 H, Ar-H) ppm. 13C NMR H), 7.36 (t, J = 7.7 Hz, 1 H, Ar-H) ppm. 13C NMR (75.4 MHz,
(75.4 MHz, CDCl3): δ = 8.1 (CH3C-4), 9.8 (CH3C-5), 45.2
(PhCH2N-3), 117.2 (C-4), 127.0 (2 C, arom. CH), 127.7 (arom.
CDCl3): δ = 9.4 (CH3C-4), 21.2 (CH3Ar), 123.9 (C-5, arom. CH),
124.6 (C-4), 127.5 (arom. CH), 129.2 (arom. CH), 129.3 (arom.
CH), 128.7 (2 C, arom. CH), 131.5 (C-5), 136.4 (arom. C), 155.9 CH), 133.1 (arom. C), 139.6 (arom. C), 155.1 (C-2) ppm. IR (film):
(C-2) ppm. IR (film): ν = 1745, 1704, 1371, 755 cm–1. MS (70 eV): ν = 1754, 1608, 1590, 1492, 1439, 1383, 1294, 1201, 1143, 1079,
˜
˜
m/z (%) = 203 (100) [M]+, 112 (3), 91 (50), 65 (12). C12H13NO 791, 773, 700 cm–1. MS (70 eV): m/z (%) = 189 (15) [M]+, 132 (26),
(203.24): calcd. C 70.92, H 6.45, N 6.89; found C 71.16, H 6.68, N
91 (100), 65 (75), 63 (20), 51 (12), 39 (65). C11H11NO2 (189.21):
6.97. Data for 11a: Rf = 0.20 (hexane/EtOAc, 7:3); m.p. 122– calcd. C 69.83, H 5.86, N 7.40; found C 69.78, H 5.76, N 7.31.
1
123 °C. H NMR (300 MHz, CDCl3): δ = 1.85 (s, 6 H, 2 CH3C),
3,4,5-Triphenyl-4-oxazolin-2-one (10a): Synthesized according to
method A, with 3c (2.12 g) and 4a (1.19 g), 10a (2.53 g, 81%) was
4.87 (s, 4 H, 2 PhCH2N), 7.20–7.38 (m, 10 H, 2 Ph-H) ppm. 13C
NMR (75.4 MHz, CDCl3): δ = 8.6 (2 CH3C), 44.6 (2 PhCH2N),
afforded as a white powder (EtOAc). Rf = 0.50 (hexane/EtOAc,
7:3); m.p. 219–220 °C (ref.[23] 211 °C).
113.4 (C-4, C-5), 127.0 (4 C, arom. CH), 127.2 (2 C, arom. CH),
128.6 (4 C, arom. CH), 138.1 (2 C, arom. C), 153.8 (C-2) ppm. IR
N-(2-Chloroethyl)-4,5-diphenyl-4-oxazolin-2-one (10b) and 1,3-
Bis(2-chloroethyl)-4,5-diphenyl-1H-imidazol-2(3H)-one (11b): Syn-
thesized according to method A, with 3c (2.12 g) and 4h (1.05 g),
10b (1.49 g, 50%) as a white powder and 11b (0.214 g, 6%) as col-
orless crystals were afforded. Data for 10b: Rf = 0.50 (hexane/
EtOAc, 7:3); m.p. 104–105 °C. 1H NMR (300 MHz, CDCl3): δ =
3.61 (t, J = 6.2, Hz, 2 H, ClCH2CH2N-3), 3.79 (t, J = 6.2, Hz, 2
H, ClCH2CH2N-3), 7.18–7.28 (m, 5 H, Ph-H), 7.42–7.48 (m, 2 H,
Ph-H), 7.52–7.59 (m, 3 H, Ph-H) ppm. 13C NMR (75.4 MHz,
CDCl3): δ = 40.2 (ClCH2CH2N-3), 43.3 (ClCH2CH2N-3), 123.1
(C-4), 124.3 (2 C, arom. CH), 126.6 (arom. C), 127.5 (arom. C),
127.8 (arom. CH), 128.5 (2 C, arom. CH), 129.7 (2 C, arom. CH),
130.4 (arom. CH), 130.7 (2 C, arom. CH), 134.8 (C-5), 154.3 (C-
(film): ν = 2929, 1708, 1654 cm–1. 1496, 1444, 1356, 1182, 1075,
˜
700 cm–1. MS (70 eV): m/z (%) = 292 (3) [M]+, 92 (8), 91 (100),
65 (15). HRMS (EI): calcd. for C19H20N2O [M]+ 292.1576; found
292.1584.
N-(2-Chloroethyl)-4,5-dimethyl-4-oxazolin-2-one (1h):[9] Synthesized
according to method A, with 3a (0.88 g) and 4h (1.05 g), 1e
(0.545 g, 31%) was afforded as a reddish oil. Rf = 0.50 (hexane/
EtOAc, 7:3).
4-Methyl-N-phenyl-4-oxazolin-2-one (9a): Synthesized according to
method A, with 3b (0.74 g) and 4a (1.19 g), 9a (1.365 g, 78%) was
afforded as colorless crystals (hexane/CH2Cl2, 1:6). Synthesized ac-
cording to method B, with 3b (0.10 g, 1.34 mmol) and 4a (0.19 g,
1.62 mmol), 9a (0.196 g, 83%) was afforded. Synthesized according
to method C, with 3b (0.10 g, 1.34 mmol), 4a (0.19 g, 1.62 mmol),
and Et3N (0.13 g, 1.35 mmol), 9a (0.158 g, 66%) was afforded. Rf
= 0.31 (hexane/EtOAc, 7:3); m.p. 58–59 °C. 1H NMR (300 MHz,
CDCl3): δ = 1.92 (d, J = 1.5 Hz, 3 H, CH3C-4), 6.71 (q, J = 1.5 Hz,
1 H, 5-H), 7.30–7.38 (m, 2 H, Ph-H), 7.40–7.55 (m, 3 H, Ph-
H) ppm. 13C NMR (75.4 MHz, CDCl3): δ = 9.5 (CH3C-4), 124.0
(C-5), 124.5 (C-4), 126.9 (2 C, arom. CH), 128.5 (arom. CH), 129.5
2) ppm. IR (film): ν = 1758, 1445, 1381, 1059, 758, 700 cm–1. MS
˜
(70 eV): m/z (%) = 300 (1) [M]+, 166 (5), 105 (50), 104 (96), 103
(100), 89 (15), 77 (98), 63 (65), 51 (52). C17H14ClNO2 (299.75):
calcd. C 68.12, H 4.71, N 4.67; found C 68.35, H 4.63, N 4.66.
1
Data for 11b: Rf = 0.20 (hexane/EtOAc, 7:3); m.p. 114–115 °C. H
NMR (300 MHz, CDCl3): δ = 3.62 (t, J = 6.8, Hz, 4 H,
ClCH2CH2N-3), 4.00 (t, J = 6.8, Hz, 4 H, ClCH2CH2N-3), 7.14–
7.22 (m, 4 H, Ph-H), 7.25–7.36 (m, 6 H, Ph-H) ppm. 13C NMR
(75.4 MHz, CDCl3):
δ = 40.9 (2 ClCH2CH2N-3), 43.1 (2
(2 C, arom. CH), 133.3 (arom. C), 155.0 (C-2) ppm. IR (film): ν =
˜
ClCH2CH2N-3), 121.2 (C-4, C-5), 128.3 (2 C, arom. C), 128.4 (2
C, arom. CH), 128.6 (4 C, arom. CH), 130.4 (4 C, arom. CH),
1754, 1665, 1597, 1502, 1396, 1385, 1278, 1152, 1076, 966, 762,
694 cm–1. MS (70 eV): m/z (%) = 175 (46) [M+], 118 (100), 103 (40),
91 (3), 77 (44), 52 (20). C10H9NO2 (175.18): calcd. C 68.56, H 5.18,
N 8.00; found C 68.42, H 4.95, N 8.25.
153.2 (C-2) ppm. IR (film): ν = 3055, 2961, 1687, 1500, 1446, 1397,
˜
1362, 1262, 1017, 760, 705 cm–1. MS (70 eV): m/z (%) = 364 (18)
[M + 4]+, 362 (64) [M + 2]+, 360 (100) [M]+, 298 (50), 249 (24),
236 (26), 206 (78), 179 (18), 105 (12), 77 (10). C19H18Cl2N2O
(361.27): calcd. C 63.17, H 5.02, N 7.75; found C 63.05, H 5.00, N
7.72.
N-(4-Anisyl)-4-methyl-4-oxazolin-2-one (9b): Synthesized according
to method A, with 3b (0.74 g) and 4d (1.49 g), 9b (1.645 g, 80%)
was afforded as a white powder. Rf = 0.40 (hexane/EtOAc, 7:3);
m.p. 103–104 °C. 1H NMR (300 MHz, CDCl3): δ = 1.88 (d, J =
1.7 Hz, 3 H, CH3C-4), 3.84 (s, 3 H, MeO), 6.69 (q, J = 1.7 Hz, 1
H, 5-H), 6.96–7.02 (m, 2 H, Ar-H), 7.20–7.26 (m, 2 H, Ar-H) ppm.
13C NMR (75.4 MHz, CDCl3): δ = 9.4 (CH3C-4), 55.5 (OMe),
114.7 (2 C, arom. CH), 123.7 (C-5), 124.8 (C-4), 125.8 (arom. C),
128.3 (2 C, arom. CH), 155.4 (C-2), 159.5 (arom. C) ppm. IR (film):
(4R*,5S*)-4-Hydroxy-4,5-dimethyl-N-phenyl-2-oxazolidinone (anti-
5a) and (4R*,5R*)-4-Hydroxy-4,5-dimethyl-N-phenyl-2-oxazolidi-
none (syn-5a): A mixture of 3a (0.88 g, 0.01 mol) and 4a (1.19 g,
0.01 mol) was placed in a threaded ACE glass pressure tube with
a sealed Teflon screw cap under N2. The mixture was stirred and
irradiated with MW (200 W) at 100 °C for 60 min. The mixture
was diluted in CH2Cl2 (40 mL), poured into H2O (100 mL), stirred
for 30 min, and the precipitate filtered. The aqueous layer was
washed with CH2Cl2 (2ϫ40 mL), the combined organic layers were
dried (Na2SO4), and the solvent removed under vacuum. The resi-
ν = 1750, 1515, 1396, 1298, 1251, 1154, 1078, 968, 836 cm–1. MS
˜
(70 eV): m/z (%) = 205 (10) [M]+, 148 (12), 107 (15), 77 (100), 63
(42). C11H11NO3 (205.21): calcd. C 64.38, H 5.40, N 6.83; found C
64.13, H 5.41, N 7.00.
4-Methyl-N-(3-tolyl)-4-oxazolin-2-one (9c): Synthesized according due was purified by column chromatography on silica gel (30 g per
to method A, with 3b (0.74 g) and 4i (1.33 g), 9c (1.47 g, 78%) was
afforded as colorless crystals (hexane/CH2Cl2, 1:6). Synthesized ac-
cording to method B, with 3b (0.10 g, 1.34 mmol) and 4i (0.22 g,
1.63 mmol), 9c (0.216 g, 84%) was afforded. Synthesized according
gram of crude, hexane/EtOAc, 9:1) to give a mixture of anti-5a-/
syn-5a (85:15, 1.61 g, 78%), which after recrystallization (hexane/
CH2Cl2, 1:1) afforded anti-5a (1.26 g, 61%) as colorless crystals. Rf
= 0.55 (hexane/EtOAc, 1:1); m.p. 102–104 °C (ref.[9] 97–99 °C).
Eur. J. Org. Chem. 2009, 2505–2518
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
2513